Showing results (481-490 of 520) with videos related to
Sort By:
Pageof 52
ACS Applied Materials & Interfaces|December 17, 2024
Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1Jonathan S Rink, Adam Y Lin, Andrea E Calvert, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.Molecular Therapy Oncolytics|March 19, 2021
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivoJayeeta Ghose, Ada Dona, Mariam Murtadha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin LymphomaRobert Chen, Alex F Herrera, Jessie Hou, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Single-cell transcriptomics reveal diverging pathobiology and opportunities for precision targeting in scleroderma-associated versus idiopathic pulmonary arterial hypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.Nature Communications|December 2, 2025
DDX6 undergoes phase separation to modulate metabolic plasticity and chemoresistanceHongjie Bi, Wei Li, Lili Ren, et al.Leukemia|April 20, 2024
8-Cl-Ado and 8-NH2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemiaJiamin Guo, Ralf Buettner, Li Du, et al.Circulation. Genomic and Precision Medicine|July 21, 2025
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial HypertensionTijana Tuhy, Julie C Coursen, Tammy Graves, et al.Blood Cancer Discovery|April 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLLYiming Wu, Meiling Jin, Mike Fernandez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Revised response criteria for malignant lymphomaBruce D Cheson, Beate Pfistner, Malik E Juweid, et al.Pageof 52